Home > Boards > US OTC > Biotechs > Aileron Therapeutics, Inc. (ALRN)

WATERTOWN, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) --

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Hunkachunk Member Profile
 
Followed By 16
Posts 561
Boards Moderated 0
Alias Born 01/08/10
160x600 placeholder
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/30/2020 5:02:54 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/30/2020 4:03:23 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/18/2020 7:01:45 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 2/14/2020 5:54:51 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 11:12:40 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 11/12/2019 2:04:17 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 11/8/2019 4:39:26 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 6:32:33 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/30/2019 5:07:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 4:57:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 8:35:33 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/5/2019 4:10:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/4/2019 4:15:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/3/2019 5:18:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/20/2019 4:18:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/15/2019 4:17:37 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/13/2019 5:01:11 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 4:08:36 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/17/2019 6:01:03 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/16/2019 6:01:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/15/2019 4:31:48 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 7/15/2019 4:11:49 PM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 7/1/2019 4:53:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2019 5:24:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2019 5:18:45 PM
Hunkachunk   Thursday, 10/31/19 08:42:47 AM
Re: None
Post # of 15 
WATERTOWN, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ: ALRN), the clinical-stage leader in the field of stabilized, cell-permeating peptides, today announced that the Company will host a conference call and webcast at 8:30 a.m. ET on Thursday, November 7, 2019 to report its third quarter 2019 financial results and provide a corporate update.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist